- Home
- LGND
as 11-15-2024 4:00pm EST
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 2.0B | IPO Year: | 1992 |
| Target Price: | $144.83 | AVG Volume (30 days): | 142.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.47 | EPS Growth: | 160.46 |
| 52 Week Low/High: | $57.00 - $129.90 | Next Earning Date: | 11-07-2024 |
| Revenue: | $152,422,000 | Revenue Growth: | -0.76% |
| Revenue Growth (this year): | 23.19% | Revenue Growth (next year): | 15.08% |
Latest Ligand Pharmaceuticals Incorporated News
LGND Breaking Stock News: Dive into LGND Ticker-Specific Updates for Smart Investing
Simply Wall St.
20 hours ago
Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
Business Wire
3 days ago
Ligand to Present at Stifel 2024 Healthcare Conference
Argus Research
4 days ago
LGND: Raising target price to $127.00
Zacks Small Cap Research
6 days ago
LGND: 3Q Sales Surprise to the Upside
Simply Wall St.
8 days ago
Ligand Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St.
9 days ago
Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Intrinsic Value Is Potentially 99% Above Its Share Price
GuruFocus.com
9 days ago
Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
MT Newswires
10 days ago
Sector Update: Health Care Stocks Rise Late Afternoon
Compare LGND vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LGND Ligand Pharmaceuticals Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.